SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
Guotai Haitong: Still optimistic about the leading yarn companies benefiting from the rising prices of American cotton and showing financial performance flexibility.
MANYCORE TECH (00068) plans to globally issue 160.6 million shares, introducing cornerstone investors such as Sunshine Life Insurance.
A-share subscription | Shine Microelectronics (688820.SH) opens for subscription to become the largest enterprise in mainland China with a 12-inch Bumping production capacity.
Guotai Haitong: Still optimistic about the leading yarn companies benefiting from the rising prices of American cotton and showing financial performance flexibility.
MANYCORE TECH (00068) plans to globally issue 160.6 million shares, introducing cornerstone investors such as Sunshine Life Insurance.
A-share subscription | Shine Microelectronics (688820.SH) opens for subscription to become the largest enterprise in mainland China with a 12-inch Bumping production capacity.
